Krill

Chana Kranzler

Affiliation at the time of the award:

Bar-Ilan University
Faculty of Life Sciences

Award Citation:

“For her pioneering research uncovering the hidden interactions between viruses and phytoplankton, and for illuminating their critical role in global marine ecosystems.”

Phytoplankton are marine microorganisms responsible for approximately half of all photosynthesis on Earth. They produce the oxygen we breathe, regulate the climate, and form the foundation of the marine food web. These microorganisms are in constant interaction with their environment, responding to the availability of light and nutrients, the presence of neighboring organisms, and predation and infection by zooplankton and viruses.

Dr. Chana Kranzler investigates how changing environmental conditions influence the life cycle of phytoplankton, with a particular focus on their interactions with viruses. In her groundbreaking research, she combines laboratory experiments with oceanographic sampling expeditions, tracking natural populations of phytoplankton and viruses. Her goal is to understand when viral infection occurs, which environmental conditions promote or inhibit it, and how these interactions affect the broader ecosystem. Her findings have shown, for example, how deficiencies in iron or phosphorus can alter infection rates, thereby influencing the cycling of carbon, silica, and marine life.

Dr. Kranzler’s pioneering work not only reveals previously hidden biological mechanisms but also provides critical insights into the potential impacts of climate change on global marine ecosystems. She is regarded as an inspiring scientist whose curiosity, creativity, and systems-level perspective are advancing our understanding of the hidden forces that sustain life on Earth.

 Menachem (“Hemi”) Rotenberg

Affiliation at the time of the award:

Technion – Israel Institute of Technology
Faculty of Biomedical Engineering

Award Citation:

“For developing innovative wireless technologies for cellular stimulation, expanding the frontiers of bioelectronics and biomedical applications.

The cells in our bodies respond to electrical and mechanical stimuli in a variety of ways. Neurons use electrical signals to control how we think, walk, and breathe, and they also regulate the heartbeat. Our immune system is likewise activated by electrical activity, while cells grow, migrate, and regenerate in response to electrical and mechanical stimuli—such as stretching and contraction—that govern how the body heals from injury. Despite their importance, existing methods for inducing these stimuli within the body are limited: they often require wiring, physical connections, or genetic manipulation, and frequently lack the necessary spatial precision.

Dr. Rotenberg’s work is pioneering the field of bioelectronics by creatively integrating life sciences, advanced materials, and biomedical engineering. In his laboratory, he has developed novel materials and technologies for the wireless stimulation of cells—both electrical and mechanical—across multiple scales, from whole organs down to the stimulation of specific regions within a single cell. His approach employs optoelectronic nanomaterials that convert light into electrical stimulation, as well as magnetic particles that enable precise mechanical control through externally applied magnetic fields.

The technologies developed by Dr. Rotenberg offer transformative solutions to longstanding challenges in medicine and science, such as stimulating the heart using infrared light and creating magnetically coordinated environments for tissue engineering. His work provides new insights into complex biological mechanisms and supports the development of groundbreaking clinical applications—all without the need for external wiring or genetic intervention.

Yiska Weisblum

Affiliation at the time of the award:

The Hebrew University of Jerusalem
Faculty of Medicine
Department of Microbiology and Molecular Genetics

Award Citation:

Dr. Yiska Weisblum leads pioneering research focused on one of the major threats to public health—viruses with pandemic potential. The goal of her work is to predict how viruses are likely to evolve, identify their hidden vulnerabilities, and harness the body’s natural defense mechanisms to stay ahead of future outbreaks. In her research, Dr. Weisblum investigates the molecular interactions between viruses and their host cells—a complex network of interactions that influences patterns of infection and transmission. Understanding this “molecular game of chess” is essential not only for treating existing viruses but also for preparing for future pandemics. Using advanced genetic tools, she has uncovered previously unknown immune defense mechanisms, as well as viral weaknesses that may serve as targets for the development of new drugs and vaccines.

During the COVID-19 pandemic, Dr. Weisblum was among the first researchers to predict the emergence of new viral variants before they became widespread in the population. She also identified promising antibody-based treatments. As part of efforts to prepare for future threats, she is developing non-pathogenic viral models that enable the safe study of how animal viruses adapt to infect humans. These models also serve as platforms for vaccine development.

Yonatan Belinkov

Affiliation at the time of the award:

Technion – Israel Institute of Technology
Taub Faculty of Computer Science

Award Citation:

“For his innovative contributions to elucidating the internal mechanisms of artificial intelligence systems and developing methods to intervene in their computations.”

Dr. Yonatan Belinkov is a researcher in the fields of natural language processing and artificial intelligence. His research addresses a fundamental question: how do deep learning systems that generate text, images, and insights actually work, despite remaining “black boxes” – transparent in their outputs but opaque in their internal mechanisms? Dr. Belinkov develops methods for analyzing, understanding, and intervening in these models in order to uncover how meaning is represented, how biases emerge, and how incorrect information can be corrected.

His work combines advanced computational approaches with principles from linguistics, extending the reach of artificial intelligence into fields such as computational biology – for example, by building connections between different “languages,” such as human language and the language of DNA. Alongside his fundamental research, he has made major contributions to the precise control of large AI models, including the identification of individual neurons responsible for specific syntactic properties or factual knowledge.

Dr. Belinkov’s influence within the international research community is evident both in establishing new theoretical foundations and in shaping entire lines of research. His pioneering work sheds light on the inner workings of artificial intelligence systems and advances our ability to understand, interpret, and exert control over the technologies that are increasingly shaping our digital world.

Yiska Weisblum

Affiliation at the time of the award:

The Hebrew University of Jerusalem
Faculty of Medicine
Department of Microbiology and Molecular Genetics

Award Citation:

” For her contributions to understanding the interactions between viruses and the immune system, and for developing innovative approaches to addressing future pandemics.”

Dr. Yiska Weisblum leads pioneering research focused on one of the major threats to public health-viruses with pandemic potential. The goal of her work is to predict how viruses are likely to evolve, identify their hidden vulnerabilities, and harness the body’s natural defense mechanisms to stay ahead of future outbreaks. In her research, Dr. Weisblum investigates the molecular interactions between viruses and their host cells-a complex network of interactions that influences patterns of infection and transmission. Understanding this “molecular game of chess” is essential not only for treating existing viruses but also for preparing for future pandemics. Using advanced genetic tools, she has uncovered previously unknown immune defense mechanisms, as well as viral weaknesses that may serve as targets for the development of new drugs and vaccines.

During the COVID-19 pandemic, Dr. Weisblum was among the first researchers to predict the emergence of new viral variants before they became widespread in the population. She also identified promising antibody-based treatments. As part of efforts to prepare for future threats, she is developing non-pathogenic viral models that enable the safe study of how animal viruses adapt to infect humans. These models also serve as platforms for vaccine development.

Today, Dr. Weisblum continues to lead groundbreaking research in her laboratory, integrating genomics, virology, and synthetic biology. Her work advances our understanding of the immune system and expands the scientific tools available for combating future pandemics.

Yiska Weisblum

Affiliation at the time of the award:

The Hebrew University of Jerusalem
Faculty of Medicine
Department of Microbiology and Molecular Genetics

Award Citation:

” For her contributions to understanding the interactions between viruses and the immune system, and for developing innovative approaches to addressing future pandemics.”

Dr. Yiska Weisblum leads pioneering research focused on one of the major threats to public health-viruses with pandemic potential. The goal of her work is to predict how viruses are likely to evolve, identify their hidden vulnerabilities, and harness the body’s natural defense mechanisms to stay ahead of future outbreaks. In her research, Dr. Weisblum investigates the molecular interactions between viruses and their host cells-a complex network of interactions that influences patterns of infection and transmission. Understanding this “molecular game of chess” is essential not only for treating existing viruses but also for preparing for future pandemics. Using advanced genetic tools, she has uncovered previously unknown immune defense mechanisms, as well as viral weaknesses that may serve as targets for the development of new drugs and vaccines.

During the COVID-19 pandemic, Dr. Weisblum was among the first researchers to predict the emergence of new viral variants before they became widespread in the population. She also identified promising antibody-based treatments. As part of efforts to prepare for future threats, she is developing non-pathogenic viral models that enable the safe study of how animal viruses adapt to infect humans. These models also serve as platforms for vaccine development.

Today, Dr. Weisblum continues to lead groundbreaking research in her laboratory, integrating genomics, virology, and synthetic biology. Her work advances our understanding of the immune system and expands the scientific tools available for combating future pandemics.